<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Value Research Online</title>
        <atom:link href="/stories/stock/41832/divi-s-laboratories-ltd/rss/" rel="self" type="application/rss+xml" />
        <link>https://www.valueresearchonline.com/</link>
        <description>RSS Feeds | Value Research</description>
        <language>en</language>
        <copyright>Copyright 2026 Value Research India Private Limited.</copyright>
        <image>
            <title>Value Research</title>
            <url>https://www.valueresearchonline.com/assets/images/valueresearchonline-desktop.png</url>
            <link>https://www.valueresearchonline.com/</link>
        </image>

        <item>
			<title>Divi's Labs gains 5% on strong Q3 performance</title>
			<link>https://www.valueresearchonline.com/stories/223026/divis-labs-q3-results-stock-gains-5-on-strong-q3-performance/</link>
			<pubDate>Mon, 03 Feb 2025 18:14:44 +0530</pubDate>
			<category>Newswire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/223026_divis_labs_gains_5_on_strong_q3_performance__w320__h240__.jpg&quot; alt=&quot;Divi’s Labs Q3 results: Stock gains 5% on strong Q3 performance&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Divi&#039;s Laboratories shares hit Rs 5,889 as Q3 profit jumps 65% to Rs 589 crore. Revenue grows 25% YoY, operating margins expand 6.5%.</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/223026/divis-labs-q3-results-stock-gains-5-on-strong-q3-performance/</guid>
		</item>
		<item>
			<title>Is the worst over for Divi's?</title>
			<link>https://www.valueresearchonline.com/stories/52139/is-the-worst-over-for-divi-s/</link>
			<pubDate>Fri, 10 Feb 2023 15:07:22 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/52139_divi__w320__h240__.jpg&quot; alt=&quot;Is the worst over for Divi’s?&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;We explain why there was a drastic downturn and what the future holds for Divi&#039;s</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/52139/is-the-worst-over-for-divi-s/</guid>
		</item>
		<item>
			<title>Value your funds</title>
			<link>https://www.valueresearchonline.com/stories/35074/value-your-funds/</link>
			<pubDate>Mon, 29 Jan 2018 12:45:55 +0530</pubDate>
			<category>Fundwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/35074_20180129-fundwire-valuefunds-1000x750__w320__h240__.jpg&quot; alt=&quot;Value your funds&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Value funds have out-performed benchmark indices over the long-term as well as short-term</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/35074/value-your-funds/</guid>
		</item>
		<item>
			<title>Premium pharma player: Divis Labs</title>
			<link>https://www.valueresearchonline.com/stories/34878/premium-pharma-player-divis-labs/</link>
			<pubDate>Thu, 21 Dec 2017 09:00:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/34878_divis-labs__w320__h240__.jpg&quot; alt=&quot;Premium pharma player: Divis Labs&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Divis generated an average ROCE of 33 per cent, which is one of the best among its peers</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/34878/premium-pharma-player-divis-labs/</guid>
		</item>
		<item>
			<title>How to spot current performers</title>
			<link>https://www.valueresearchonline.com/stories/30379/how-to-spot-current-performers/</link>
			<pubDate>Mon, 22 Feb 2016 01:24:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>The F-Score, which is a nine-point scale, helps you find out the companies that have outperformed in the last one year></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/30379/how-to-spot-current-performers/</guid>
		</item>
		<item>
			<title>The quest for value</title>
			<link>https://www.valueresearchonline.com/stories/29141/the-quest-for-value/</link>
			<pubDate>Tue, 20 Oct 2015 17:56:55 +0530</pubDate>
			<category>Marketwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/29141_29141__w320__h240__.jpg&quot; alt=&quot;The quest for value&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;There is little value in the stocks of the three main defensive sectors: FMCG, pharma and technology</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29141/the-quest-for-value/</guid>
		</item>
		<item>
			<title>The Money-maker</title>
			<link>https://www.valueresearchonline.com/stories/27832/the-money-maker/</link>
			<pubDate>Wed, 06 May 2015 11:49:56 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>No company across sectors can match the close to 40 per cent ten-year margins of Divi&#039;s Laboratories></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/27832/the-money-maker/</guid>
		</item>
		<item>
			<title>The Rupee Bonanza</title>
			<link>https://www.valueresearchonline.com/stories/23517/the-rupee-bonanza/</link>
			<pubDate>Thu, 05 Sep 2013 12:53:00 +0530</pubDate>
			<category>Special Report</category>
			<description>That rupee was in a downcast mood was evident since last year, but there are those that stand to gain from the decline></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/23517/the-rupee-bonanza/</guid>
		</item>
		<item>
			<title>The King of CRAMS</title>
			<link>https://www.valueresearchonline.com/stories/22050/the-king-of-crams/</link>
			<pubDate>Fri, 01 Feb 2013 12:00:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>Divi&#039;s Laboratories has excelled in contract research &amp; manufacturing services, making it a worthy investment pick... ></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/22050/the-king-of-crams/</guid>
		</item>
		<item>
			<title>Zipping Ahead</title>
			<link>https://www.valueresearchonline.com/stories/15159/zipping-ahead/</link>
			<pubDate>Fri, 10 Sep 2010 09:41:00 +0530</pubDate>
			<category>Fund Focus</category>
			<description>Reliance Equity Opportunity fund has thrown up some interesting numbers, but we advise you against making it a core holding></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/15159/zipping-ahead/</guid>
		</item>
		<item>
			<title>A Diversified Holding</title>
			<link>https://www.valueresearchonline.com/stories/14777/a-diversified-holding/</link>
			<pubDate>Thu, 08 Jul 2010 09:47:00 +0530</pubDate>
			<category>Fund Focus</category>
			<description>The largest fund in its category in terms of AUM, Reliance Growth is ideal for all portfolio types....></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/14777/a-diversified-holding/</guid>
		</item>
		<item>
			<title>HDFC Growth</title>
			<link>https://www.valueresearchonline.com/stories/14508/hdfc-growth/</link>
			<pubDate>Tue, 25 May 2010 10:07:00 +0530</pubDate>
			<category>Fund Focus</category>
			<description>Uneven Ride></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/14508/hdfc-growth/</guid>
		</item>
		<item>
			<title>The Biggest Purchases</title>
			<link>https://www.valueresearchonline.com/stories/11676/the-biggest-purchases/</link>
			<pubDate>Fri, 25 Jul 2008 17:01:00 +0530</pubDate>
			<category>Fundwire</category>
			<description>Bharti Airtel was the most bought stock by funds in the past 6 months. Here are the other major purchases></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/11676/the-biggest-purchases/</guid>
		</item>
    </channel>
</rss>
